Essential-Biotic® COMPLETE
Allergy Research Group Essential-Biotic® COMPLETE
Shelf-stable, Broad-spectrum Probiotic 50 billion CFUs
Twelve human probiotic strains to support both upper and lower GI health. 50 billion CFUs per delayed-release vegetarian capsule. Non-dairy, gluten-free, and stable at room temperature - no refrigeration required.
Ingredients
| Serving Size: 1 Vegetarian Capsule | Amount/Serving |
| Proprietary Blend: | 347 mg (50 Billion CFU) |
|
Lactobacillus plantarum UALp-05™ |
Other Ingredients: Microcrystalline cellulose, Nu-MAG® (rice extract, rice hulls, gum arabic, sunflower oil), silicon dioxide, purified water, gellan gum, pectin.
Suggested Use
As a dietary supplement, take 1 capsule twice daily, or as directed by a healthcare practitioner.
Warning: If you are pregnant or lactating, have any health condition or are taking any medication, consult your healthcare practitioner before use.
Storage: Store in a cool, dry place, tightly capped, away from light. Keep out of the reach of children. Use only if safety seal is intact. Variations in product color may occur. Shelf stable. Refrigeration not needed.
More Info
From birth to old age, our intestinal landscape is an ever-shifting balance of health-promoting organisms (probiotics) and problematic ones. Long used safely in food, modern research confirms the safety and sustainability of Bifidobacterium and Lactobacillus oral probiotic species. Probiotics beneficially affect the intestinal microbiota via local and systemic immune mechanisms as well as non-immune mechanisms. Various structure/function benefits can accrue, including the following:
Competition with microbial pathogens for nutrients and adhesion sites
- Production of bacteriocins that help control pathogen growth
- Alteration of local pH to create an unfavorable local environment for pathogens
- Enhancement of intestinal barrier function
- Stimulation of epithelial mucin production
- Increased production of short-chain fatty acids in the colon
- Augmentation of mucosal immunity through enhanced secretory IgA production
- Reduction of systemic antigen exposure (e.g. food allergens)
- Systemic immune modulation
The human gastrointestinal tract harbors between 10 trillion and 100 trillion microorganisms, comprised of hundreds of bacterial species. But we don’t start out that way. The newborn’s initial gut endowment is limited to a few types of organisms and gradually changes until it reaches a high diversity like the adult gut by 1 to 2 years of age. This development is affected by whether the birth was vaginal or cesarean section, as well as whether the first food was breast milk or formula. Infants born vaginally have increased bacterial diversity or “richness” in the gut, increased chances for normal weight, and other health parameters. Breastfed infants typically have a bifidobacteria-dominated microbiota, most likely due to the presence of prebiotic breast milk oligosaccharides as well as probiotic organisms in breast milk.
Improper acquisition of a diverse and balanced microbiota during infancy and early childhood may have an adverse impact on health into adulthood. Healthy initial colonization can influence gut maturation and immune, brain, and metabolic development.
Whether young or old, male or female, the human gastrointestinal tract may benefit from evidence-based strains, hypoallergenically formulated and safely delivered
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Allergy Research Group Essential-Biotic® COMPLETE
Shelf-stable, Broad-spectrum Probiotic 50 billion CFUs
Twelve human probiotic strains to support both upper and lower GI health. 50 billion CFUs per delayed-release vegetarian capsule. Non-dairy, gluten-free, and stable at room temperature - no refrigeration required.
Ingredients
| Serving Size: 1 Vegetarian Capsule | Amount/Serving |
| Proprietary Blend: | 347 mg (50 Billion CFU) |
|
Lactobacillus plantarum UALp-05™ |
Other Ingredients: Microcrystalline cellulose, Nu-MAG® (rice extract, rice hulls, gum arabic, sunflower oil), silicon dioxide, purified water, gellan gum, pectin.
Suggested Use
As a dietary supplement, take 1 capsule twice daily, or as directed by a healthcare practitioner.
Warning: If you are pregnant or lactating, have any health condition or are taking any medication, consult your healthcare practitioner before use.
Storage: Store in a cool, dry place, tightly capped, away from light. Keep out of the reach of children. Use only if safety seal is intact. Variations in product color may occur. Shelf stable. Refrigeration not needed.
More Info
From birth to old age, our intestinal landscape is an ever-shifting balance of health-promoting organisms (probiotics) and problematic ones. Long used safely in food, modern research confirms the safety and sustainability of Bifidobacterium and Lactobacillus oral probiotic species. Probiotics beneficially affect the intestinal microbiota via local and systemic immune mechanisms as well as non-immune mechanisms. Various structure/function benefits can accrue, including the following:
Competition with microbial pathogens for nutrients and adhesion sites
- Production of bacteriocins that help control pathogen growth
- Alteration of local pH to create an unfavorable local environment for pathogens
- Enhancement of intestinal barrier function
- Stimulation of epithelial mucin production
- Increased production of short-chain fatty acids in the colon
- Augmentation of mucosal immunity through enhanced secretory IgA production
- Reduction of systemic antigen exposure (e.g. food allergens)
- Systemic immune modulation
The human gastrointestinal tract harbors between 10 trillion and 100 trillion microorganisms, comprised of hundreds of bacterial species. But we don’t start out that way. The newborn’s initial gut endowment is limited to a few types of organisms and gradually changes until it reaches a high diversity like the adult gut by 1 to 2 years of age. This development is affected by whether the birth was vaginal or cesarean section, as well as whether the first food was breast milk or formula. Infants born vaginally have increased bacterial diversity or “richness” in the gut, increased chances for normal weight, and other health parameters. Breastfed infants typically have a bifidobacteria-dominated microbiota, most likely due to the presence of prebiotic breast milk oligosaccharides as well as probiotic organisms in breast milk.
Improper acquisition of a diverse and balanced microbiota during infancy and early childhood may have an adverse impact on health into adulthood. Healthy initial colonization can influence gut maturation and immune, brain, and metabolic development.
Whether young or old, male or female, the human gastrointestinal tract may benefit from evidence-based strains, hypoallergenically formulated and safely delivered
